Logotipo del repositorio
 

BIOLOGÍA DE LAS CÉLULAS DENDRÍTICAS HUMANAS

dc.contributornull
dc.contributor.authorCuéllar Ávila, Adriana; Grupo de Inmunobiología y Biología Celular Departamento de Microbiología Facultad de Ciencias Pontificia Universidad Javeriana, Bogotá
dc.contributor.authorCifuentes Rojas, Catherine; Grupo de Inmunobiología y Biología Celular Departamento de Microbiología Facultad de Ciencias Pontificia Universidad Javeriana, Bogotá
dc.contributor.authorGómez Gutiérrez, Alberto; Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá Departamento de Microbiología Facultad de Ciencias Pontificia Universidad Javeriana, Bogotá
dc.contributor.authorGonzález Escobar, John Mario; Grupo de Inmunobiología y Biología Celular Departamento de Microbiología Facultad de Ciencias Pontificia Universidad Javeriana, Bogotá Department of Neurology, Keck Medical School, University of Southern California, Los Angeles, CA, USA.
dc.coveragenull
dc.coveragenull
dc.coveragenull
dc.date.accessioned2018-02-24T16:00:39Z
dc.date.accessioned2020-04-15T18:08:27Z
dc.date.available2018-02-24T16:00:39Z
dc.date.available2020-04-15T18:08:27Z
dc.date.created2004-01-10
dc.description.abstractAntigen presenting cells are capable of capturing and processing antigenic peptides to be presented to T lymphocytes in the context of the Major Histocompatibility Complex. These peptides derived from self or no self proteins could be recognized  by the T Cell Receptor expressed on the surface of T lymphocytes. However, this presentation is not enough to activate peptide specific T lymphocytes. Dendritic cells are potent antigen presenting cells and  also have the capability to generate a second signal to stimulate T cell response. Currently, dendritic cells seem to play a central role in the  development of autoimmune diseases and also in the immune response  to microbial and tumoral antigens. The active study of their function and the possibility to purify dendritic cells form peripheral blood and even differentiate them in vitro from blood precursors will allow future and new  immune therapies for several diseases.spa
dc.formatPDFspa
dc.format.mimetypeapplication/pdfspa
dc.identifierhttp://revistas.javeriana.edu.co/index.php/scientarium/article/view/4917
dc.identifier.issn2027-1352
dc.identifier.issn0122-7483
dc.identifier.urihttp://hdl.handle.net/10554/31791
dc.language.isoeng
dc.publisherPontificia Universidad Javerianaeng
dc.relation.citationissueUniversitas Scientiarum; Vol 9, No 1 (2004); 5-12eng
dc.relation.citationissueUniversitas Scientiarum; Vol 9, No 1 (2004); 5-12spa
dc.relation.citationissueUniversitas Scientiarum; Vol 9, No 1 (2004); 5-12por
dc.relation.urihttp://revistas.javeriana.edu.co/index.php/scientarium/article/view/4917/3792
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.licenceAtribución-NoComercial-SinDerivadas 4.0 Internacional*
dc.subjectnullspa
dc.subjectCytokines, dendritic cells, monocytes, GM-CSF, IL-4.spa
dc.subjectnullspa
dc.titleBIOLOGÍA DE LAS CÉLULAS DENDRÍTICAS HUMANASspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.localArtículo de revistaspa

Archivos